Safety/toxicity evaluation of a new Ayurveda drug formulation Sudarshana Suspensio
Phase 1
- Conditions
- Fever (proposed indication)
- Registration Number
- SLCTR/2015/005
- Lead Sponsor
- HETC Project, Ministry of Higher Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow up complete
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
1.Age group of 18-60 years at the time of enrollment, of either sex with weight less than 60kg
2.Those who have no known systemic disorders, such as hypertension, diabetes mellitus, hypercholesterolemia and chronic arthritis
3. Those who have no history of drug allergy.
4.Those who have no history of intolerance to Sudarshana Powder or similar compounds
5. Women should be non pregnant and non breast feeding.
6. Only those who can write and read languages of English or Sinhala.
Exclusion Criteria
Concurrent treatment with any Ayurveda or Western medicine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method